Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Q
348080
vs
K
KOSPI 200
Over the past 12 months, Quratis Inc has underperformed KOSPI 200, delivering a return of -55% compared to KOSPI 200's +119% growth.
Stocks Performance
348080 vs KOSPI 200
Performance Gap
348080 vs KOSPI 200
Performance By Year
348080 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Quratis Inc
Glance View
Quratis, Inc. engages in the research and development of medicine and pharmaceutical products. The company is headquartered in Cheongju, Chungcheongbuk-Do and currently employs 47 full-time employees. The company went IPO on 2023-06-15. The firm is engaged in the manufacture and sale of vaccine, peptide nucleic acid complex. The firm is also engaged in the provision of Cell Penetrating Peptide (CPP) platform services. In addition, the Company is engaged in the development and research of vaccines, such as tuberculosis vaccines for adults and adolescents, and COVID-19 vaccines.